6H5F image
Deposition Date 2018-07-24
Release Date 2019-08-28
Last Version Date 2024-11-13
Entry Detail
PDB ID:
6H5F
Keywords:
Title:
LtgA disordered Helix
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Putative soluble lytic murein transglycosylase
Gene (Uniprot):NMB1949
Chain IDs:A
Chain Length:616
Number of Molecules:1
Biological Source:Neisseria meningitidis NM422
Primary Citation
Defective lytic transglycosylase disrupts cell morphogenesis by hindering cell wall de-O-acetylation inNeisseria meningitidis.
Elife 9 ? ? (2020)
PMID: 32022687 DOI: 10.7554/eLife.51247

Abstact

Lytic transglycosylases (LT) are enzymes involved in peptidoglycan (PG) remodeling. However, their contribution to cell-wall-modifying complexes and their potential as antimicrobial drug targets remains unclear. Here, we determined a high-resolution structure of the LT, an outer membrane lipoprotein from Neisseria species with a disordered active site helix (alpha helix 30). We show that deletion of the conserved alpha-helix 30 interferes with the integrity of the cell wall, disrupts cell division, cell separation, and impairs the fitness of the human pathogen Neisseria meningitidis during infection. Additionally, deletion of alpha-helix 30 results in hyperacetylated PG, suggesting this LtgA variant affects the function of the PG de-O-acetylase (Ape 1). Our study revealed that Ape 1 requires LtgA for optimal function, demonstrating that LTs can modulate the activity of their protein-binding partner. We show that targeting specific domains in LTs can be lethal, which opens the possibility that LTs are useful drug-targets.

Legend

Protein

Chemical

Disease

Primary Citation of related structures